LIVOSTIN Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Livostin, and what generic alternatives are available?

Livostin is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in LIVOSTIN is levocabastine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the levocabastine hydrochloride profile page.

Summary for LIVOSTIN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	47
Patent Applications:	622
DailyMed Link:	LIVOSTIN at DailyMed

Drug patent expirations by year for LIVOSTIN

Anatomical Therapeutic Chemical (ATC) Classes for LIVOSTIN

R01AC	Antiallergic agents, excl. corticosteroids
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

S01GX	Other antiallergics
S01G	DECONGESTANTS AND ANTIALLERGICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for LIVOSTIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	LIVOSTIN	levocabastine hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	020219-001	Nov 10, 1993		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LIVOSTIN

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	LIVOSTIN	levocabastine hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	020219-001	Nov 10, 1993	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LIVOSTIN

See the table below for patents covering LIVOSTIN around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Hungary	183293	PROCESS FOR PREPARING 1-/CYCLOHEXYL/-4-ARYL-4-PIPERIDINE-CARBOXYLIC ACID DERIVATIVES	⤷ Try a Trial
Israel	61968		⤷ Try a Trial
Poland	127483		⤷ Try a Trial
Japan	S6034759	APPARATUS FOR FILM TREATING OF METAL OR NON-METAL WORK	⤷ Try a Trial
Japan	S6412270		⤷ Try a Trial
Norway	841500		⤷ Try a Trial
Spain	8204421		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for LIVOSTIN

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0034415	SPC/GB95/006	United Kingdom	⤷ Try a Trial	SPC/GB95/006, EXPIRES: 20060110
0034415	93C0014	Belgium	⤷ Try a Trial	PRODUCT NAME: LEVOCABASTINE HYDROCHLORIDE; NAT. REG.: 2S 400 F 11 19910604; FIRST REG.: DK 8252 19910111
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Summary for LIVOSTIN

Anatomical Therapeutic Chemical (ATC) Classes for LIVOSTIN

Make Better Decisions: Try a trial or see plans & pricing